Brooks Ensign

Brooks Ensign has a diverse work experience in finance and accounting roles, with a focus on the biotechnology and medical device industries. Brooks has held positions such as VP of Financial Reporting at RapidAI, where they contributed to IPO preparations, and Global Corporate Controller (Acting CFO in 2022) at Silvaco Inc, where they led IPO preparations and implemented various financial systems. Brooks also worked as the Controller at Sunesis Pharmaceuticals and TearLab Corporation, where they implemented financial systems and led teams. Additionally, they have experience as a Director of Strategic Projects at RoseRyan, providing audit and IPO advisory consulting, and as a Controller at Nervana Systems, a company acquired by Intel Corporation. Brooks has demonstrated expertise in financial management, audit preparations, and implementing financial systems.

Brooks Ensign completed their Accounting Certificate, which included all CPA coursework, as well as an AIPB Bookkeeper certification from UC San Diego between 2005 and 2008. Brooks also obtained a Master's degree in Accounting from National University. Additionally, Brooks attended Harvard Business School and Harvard College to pursue an MBA, though the specific dates of their enrollment are not provided. Lastly, they attended EDUCBA, though no information regarding the degree or field of study is available.